Construction of a lung adenocarcinoma overall survival prognostic model based on monocyte-derived macrophage signature genes and exploration of immune crosstalk plus Pan-Cancer prognostic disparities.
- DOI
- 10.1016/j.clim.2026.110790
- Published
- 2026 Nov 2
- Container
- Clinical immunology (Orlando, Fla.)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clim.2026.110790,
title = {Construction of a lung adenocarcinoma overall survival prognostic model based on monocyte-derived macrophage signature genes and exploration of immune crosstalk plus Pan-Cancer prognostic disparities.},
author = {Zhang Y and Liu L and Ma J and Xia S},
year = {2026},
journal = {Clinical immunology (Orlando, Fla.)},
doi = {10.1016/j.clim.2026.110790},
url = {https://doi.org/10.1016/j.clim.2026.110790}
}RIS
TY - JOUR TI - Construction of a lung adenocarcinoma overall survival prognostic model based on monocyte-derived macrophage signature genes and exploration of immune crosstalk plus Pan-Cancer prognostic disparities. AU - Zhang Y AU - Liu L AU - Ma J AU - Xia S PY - 2026 JO - Clinical immunology (Orlando, Fla.) DO - 10.1016/j.clim.2026.110790 UR - https://doi.org/10.1016/j.clim.2026.110790 ER -
APA
Y, Z., L, L., J, M., & S, X. (2026). Construction of a lung adenocarcinoma overall survival prognostic model based on monocyte-derived macrophage signature genes and exploration of immune crosstalk plus Pan-Cancer prognostic disparities.. Clinical immunology (Orlando, Fla.). https://doi.org/10.1016/j.clim.2026.110790
Source records
- pubmed · retrieved 2026-11-10T11:38:50.467Z